Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
New solvent-free micronization technology expanded at the Darmstadt site in Germany
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
If approved in the European Union, Fruquintinib will be the first novel targeted therapy for Metastatic Colorectal Cancer regardless of biomarker status in over a decade
The proposed facility is expected to be operational around January, 2027
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Subscribe To Our Newsletter & Stay Updated